comparemela.com

Latest Breaking News On - Augustj troendle - Page 1 : comparemela.com

Mairs & Power Inc Has $9 56 Million Holdings in Medpace Holdings, Inc (NASDAQ:MEDP)

Mairs & Power Inc. lessened its position in shares of Medpace Holdings, Inc. (NASDAQ:MEDP – Free Report) by 15.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,189 shares of the company’s stock after selling 5,902 shares during the […]

Prudential PLC Increases Position in Medpace Holdings, Inc (NASDAQ:MEDP)

Prudential PLC boosted its holdings in Medpace Holdings, Inc. (NASDAQ:MEDP – Free Report) by 12.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 24,288 shares of the company’s stock after purchasing an additional 2,762 shares during the quarter. Prudential PLC owned about 0.08% of […]

Epoch Investment Partners Inc Boosts Stake in Medpace Holdings, Inc (NASDAQ:MEDP)

Epoch Investment Partners Inc. raised its holdings in Medpace Holdings, Inc. (NASDAQ:MEDP – Free Report) by 82.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 352,463 shares of the company’s stock after acquiring an additional 159,144 shares during the period. […]

Eagle Asset Management Inc Increases Position in Medpace Holdings, Inc (NASDAQ:MEDP)

Eagle Asset Management Inc. lifted its holdings in shares of Medpace Holdings, Inc. (NASDAQ:MEDP – Free Report) by 155.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 226,435 shares of the company’s stock after acquiring an additional 137,632 shares during the quarter. […]

TD Cowen Begins Coverage on Medpace (NASDAQ:MEDP)

TD Cowen assumed coverage on shares of Medpace (NASDAQ:MEDP – Free Report) in a research report report published on Wednesday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $452.00 price objective on the stock. MEDP has been the subject of several other research reports. Guggenheim boosted their price objective on Medpace […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.